搜索临床试验以:Chimeric antigen receptor T cells
总计494296个结果
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...主动,不招人
-
Legend Biotech USA Inc主动,不招人T细胞淋巴瘤 | 难治性外周 T 细胞淋巴瘤 | 难治性皮肤 T 细胞淋巴瘤 | 复发性皮肤 T 细胞淋巴瘤 | 复发性外周 T 细胞淋巴瘤美国
-
Baylor College of MedicineThe Methodist Hospital Research Institute撤销
-
Medical College of WisconsinMiltenyi Biomedicine GmbH主动,不招人
-
St. Jude Children's Research Hospital主动,不招人
-
Memorial Sloan Kettering Cancer CenterTakeda主动,不招人华氏巨球蛋白血症 | 边缘区淋巴瘤 | 慢性淋巴细胞白血病 | 弥漫性大 B 细胞淋巴瘤 | 伯基特氏淋巴瘤 | 原发性纵隔大B细胞淋巴瘤 | 惰性非霍奇金淋巴瘤 | 原发性中枢神经系统淋巴瘤 | 转化为弥漫性大 B 细胞淋巴瘤的滤泡性淋巴瘤美国
-
University of California, San Francisco完全的难治性浆细胞骨髓瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性浆细胞骨髓瘤 | 复发性恶性肿瘤 | 难治性恶性肿瘤 | 复发性高级 B 细胞淋巴瘤 | 难治性高级 B 细胞淋巴瘤 | 复发性侵袭性非霍奇金淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性侵袭性非霍奇金淋巴瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销进行性疾病 | 复发性 B 型急性淋巴细胞白血病 | 难治性 B 型急性淋巴细胞白血病 | 难治性慢性淋巴细胞白血病 | 复发性非霍奇金淋巴瘤 | 难治性非霍奇金淋巴瘤 | 最小残留病 | 复发性慢性淋巴细胞白血病 | CD19阳性 | CD22阳性美国
-
Tceleron Therapeutics, Inc.终止
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute:Dana- Farber/Children's Hospital主动,不招人
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...主动,不招人
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, Wisconsin完全的
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense主动,不招人
-
University of Pennsylvania撤销急性淋巴细胞白血病 | 慢性淋巴细胞白血病 | 非霍奇金淋巴瘤
-
University of Pennsylvania终止
-
University of Pennsylvania终止淋巴细胞白血病 (CLL) 或小淋巴细胞淋巴瘤 (SLL)美国
-
University of PennsylvaniaUniversity of California, San Francisco终止
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; Center for Cell and Gene Therapy, Baylor College... 和其他合作者主动,不招人
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
Pack HealthNovartis; Ohio State University Comprehensive Cancer Center终止
-
Bellicum Pharmaceuticals暂停HER2阳性乳腺癌 | HER2阳性胃癌 | 实体瘤,成人 | HER-2基因扩增 | HER-2 蛋白过表达美国
-
Groupe Hospitalier Pitie-Salpetriere完全的
-
Juno Therapeutics, a Subsidiary of Celgene主动,不招人
-
Federal Research Institute of Pediatric Hematology...主动,不招人
-
Second Affiliated Hospital, School of Medicine,...邀请报名
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research Institute; Center...完全的
-
National Cancer Institute (NCI)完全的淋巴瘤,大 B 细胞,弥漫性 | 淋巴瘤,T 细胞,外周 | 淋巴瘤、大细胞、间变性 | 淋巴瘤,结外 NK-T 细胞 | 肠病相关的T细胞淋巴瘤美国
-
Loyola UniversityLeukemia Research Foundation主动,不招人
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.主动,不招人
-
Juno Therapeutics, a Subsidiary of Celgene完全的
-
Peter MacCallum Cancer Centre, Australia完全的
-
Memorial Sloan Kettering Cancer Center撤销
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang University; NanJing PLA 81 Hospital完全的
-
National Cancer Institute (NCI)终止淋巴瘤,B细胞 | 慢性淋巴细胞白血病 | 淋巴瘤,非霍奇金 | B细胞慢性淋巴细胞白血病美国
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.终止
-
Chembrain LTDUniversity of Oulu; Jyväskylä Central Hospital; Apollo Hospital, New Delhi, India主动,不招人胶质母细胞瘤 | 多形性胶质母细胞瘤 | 胶质瘤,恶性芬兰, 印度